Cargando…
Bacillus subtilis DE111 intake may improve blood lipids and endothelial function in healthy adults
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide. By 2030 it is anticipated that CVD will claim the lives of more than 24 million people. Throughout the last decade, researchers have investigated the role of the gut microbiota in the development of CVD. Evidence exi...
Autores principales: | Trotter, R.E., Vazquez, A.R., Grubb, D.S., Freedman, K.E., Grabos, L.E., Jones, S., Gentile, C.L., Melby, C.L., Johnson, S.A., Weir, T.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773468/ https://www.ncbi.nlm.nih.gov/pubmed/33161737 http://dx.doi.org/10.3920/BM2020.0039 |
Ejemplares similares
-
Examining the Gastrointestinal and Immunomodulatory Effects of the Novel Probiotic Bacillus subtilis DE111
por: Freedman, Kimberley E., et al.
Publicado: (2021) -
In vitro and in silico assessment of probiotic and functional properties of Bacillus subtilis DE111(®)
por: Mazhar, Shahneela, et al.
Publicado: (2023) -
Data on the genome analysis of the probiotic strain Bacillus subtilis GM5
por: Hadieva, G.F., et al.
Publicado: (2018) -
Functionally uncoupled transcription-translation in Bacillus subtilis
por: Johnson, Grace E, et al.
Publicado: (2020) -
Cytoplasmic Acidification and the Benzoate Transcriptome in Bacillus subtilis
por: Kitko, Ryan D., et al.
Publicado: (2009)